• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Total number of Retailer inquiries received in the month

Dictionary: The CTP Office of the Center Director receives questions and correspondence about CTP policies from all of CTP’s stakeholder groups. The Office of the Center Director’s goal is to respond to all correspondence in a timely manner. These correspondences include: general information requests, requests for technical assistance, review and comment on letters produced by the Office of the Center Director, letters expressing concerns, questions related to hearings, requests for briefings, teleconferences, videos, and documents, information provided by retailers to the FDA, and responses to FDA requests for information from retailers.

Information is current as of March 18, 2015

Fiscal Year - 2015

Skip graphic and jump to text data

TimeTargetNumber
Oct 2014N/A4
Nov 2014N/A6
Dec 2014N/A2
Jan 2015N/ATBD
Feb 2015N/ATBD
Mar 2015N/ATBD
Apr 2015N/ATBD
May 2015N/ATBD
Jun 2015N/ATBD
Jul 2015N/ATBD
Aug 2015N/ATBD
Sep 2015N/ATBD

FY 2015 YTD: 12

Total number of Retailer inquiries responded to in the month

Dictionary: The CTP Office of the Center Director receives questions and correspondence about CTP policies from all of CTP’s stakeholder groups. The Office of the Center Director’s goal is to respond to all correspondence in a timely manner. These correspondences include: general information requests, requests for technical assistance, review and comment on letters produced by the Office of the Center Director, letters expressing concerns, questions related to hearings, requests for briefings, teleconferences, videos, and documents, information provided by retailers to the FDA, and responses to FDA requests for information from retailers.

Fiscal Year - 2015

Skip graphic and jump to text data

TimeTargetNumber
Oct 2014N/A4
Nov 2014N/A6
Dec 2014N/A2
Jan 2015N/ATBD
Feb 2015N/ATBD
Mar 2015N/ATBD
Apr 2015N/ATBD
May 2015N/ATBD
Jun 2015N/ATBD
Jul 2015N/ATBD
Aug 2015N/ATBD
Sep 2015N/ATBD

FY 2015 YTD: 12

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.